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This study is part of an ongoing investigation of biomarkers in iron foundry workers exposed to
polycyclic aromatic compounds. Foundry workers with the highest exposures had elevated levels
of DNA adducts in their white blood cells in previous studies. The purpose of this study was to
characterize the nature of DNA reactive chemicals in foundry air samples through incubating the
foundry filter extract with DNA and activation enzymes. Calf thymus DNA was incubated with
foundry filter extract and activated by either rat liver activation mixture (S9 mix) or xanthine
oxidase. A complex pattern of adducts was observed on thin-layer chromatography (TLC) by the
32P-postlabeling assay. Two selected polycyclic aromatic hydrocarbons (PAHs)-1-NP- and
anti(±)benzo[alpyrene-trans-7,8-dihydrodiol-9, 1 0-epoxide [anti(±)BPDEI-DNA adducts-were
used as marker compounds in characterizing the postlabeled DNA adducts by TLC combined
with high-performance liquid chromatography (HPLC). After an initial separation of DNA adducts
by TLC, individual spots were isolated and separated further on HPLC. HPLC analysis and spiking
with anti(±)BPDE-DNA standard confirmed the co-migration of the antil(±)BPDE-DNA standard
with one PAH adduct formed by the S9 mix-activated DCM extract in calf thymus DNA.
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Introduction
Humans are exposed occupationally and exhausts (1-8). Both benzo[a]pyrene
environmentally to polycyclic aromatic (B[a]P) and 1-nitropyrene (1-NP) induce
compounds including polycyclic aromatic mutations in bacteria and tumors in exper-
hydrocarbons (PAHs) and nitrated PAHs. imental animals (9,10). B[a]P activated by
PAHs are typical compounds in the atmos- oxidative metabolism leads to the forma-
phere of coke oven, iron, and steel found- tion of epoxides and diol epoxides that
ing industries, and nitro-PAHs are found react with DNA to form a binding product
in urban air, coal fly-ash, and diesel engine with the N2 atom of guanine. Reduction
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of 1-NP leads to the formation of
N-hydroxy-1-aminopyrene that undergoes
an acid-catalyzed reaction with DNA and
generates the main reaction product of N-
(deoxyguanosin-8-yl)1-aminopyrene; two
additional 6- and 8-(deoxyguanosin-N2-
yl)-1-aminopyrene have also been charac-
terized (11,12). Oxidative metabolism of
1-NP forms 1-NP 4,5-oxide and 1-NP
9,10-oxide, which may form additional
DNA binding products (13).
DNA adducts are important biomark-
ers that provide information about expo-
sure to carcinogens, individual differences
in carcinogen metabolism, and DNA
repair. In this study PAH and nitro-PAH
adducts formed in vitro were analyzed by
the 32P-postlabeling assay combined with
high-performance liquid chromatography
(HPLC). Foundry air samples were col-
lected by a high volume stationary air sam-
pler placed near the iron casting. The
organic matter adsorbed to the particles
was extracted with dichloromethane
(DCM) and used for both chemical and
DNA adduct analysis. Calf thymus (CT)
DNA was modified in vitrowith the DCM
extract, and PAH and nitro-PAH were
activated by rat liver activation mixture (S9
mix) and xanthine oxidase. Specific 1-NP
and anti(±)benzo[a]pyrene-trans-7,8-dihy-
drodiol-9,10-epoxide [anti(±)BPDE]-
DNA adduct standards were used to char-
acterize the in vitro foundry air-derived
DNA adducts.
Methods
FoundrySamples
Air samples were collected in an iron
foundry in Finland by a high volume sta-
tionary air sampler placed 3 to 5 meters
away from the iron casting process. The
temperature of melted iron was 1380 to
14000C. The samples were drawn on four
20x20 cm Pallflex-filters (type T60A20;
Pallflex Products Corp., Putnam, CT). No
vapor-phase capture technique was used
in this study because the focus was to ana-
lyze PAH bound to the particulate matter.
Preparation of the extractable organic
material (EOM) with DCM and measure-
ments of different PAHs and nitro-PAHs
by HPLC and gas chromatography-mass
spectrometry (GS-MC) are described
elsewhere (14-16). The B[a]P concentra-
tion in the composite extract (8.2 ng/mg)
was approximately the level of 1-NP
(10.9 ng/mg). The B[a]P concentration
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corresponds to 7 to 41 ng/m3 B[a]P
analyzed from the air samples.
Modification ofCalfThymus DNA
withFoundryFilterExtract
and 1-Nitropyrene
CT DNA (2 mg/ml) was incubated with
100 pl of DCM extract (2.66mg/ml) and
1-NP (20 pg/ml) under aerobic conditions
with S9 mix (0.5 mg/ml) and under anaer-
obic conditions with xanthine oxidase (0.5
U/ml) and hypoxanthine (0.6 mg/ml) for
4 hr at 37°C as previously (14-16).
Anti(±)Benzo[a]pyrene-trans-7,8-
dihydrodiol-9,10-epoxide-DNA
Standard Preparation
The anti(±)BPDE-DNA standard was
prepared in 100 mM Tris-HCI buffer, pH
7.0, and incubated at room temperature
for 16 hr with CT DNA (1 mg/ml) with
0.1 volume of anti(±)BPDE (1 mg/ml).
The reaction mixture was extracted twice
with water-saturated butanol and with
diethylether.A.............:.......^............................................................
.: : .:.....,......................... .........:
. . . ....... ... .... .. .. .. .............S......S.......................\ ..............::..<.:a:.:.:.:::'::::::^'
32P-PosdabelingAnalysis
DNA was analyzed by the butanol extrac-
tion and nuclease P1-enhanced postlabel-
ing assay according to Gupta (17) and
Reddy and Randerath (18). The labeled
DNA adducts were resolved on 10 x 10 or
20 x20 cm polyethylene imine (PEI) cellu-
lose thin-layer chromatography (TLC)
plates (Macherey-Nagel, Duren, Germany)
using a standard solvent system previously
described (19), with the exception that
1.7 M sodium phosphate, pH 6, was used
for D5. The radioactive areas of adducts
were located by autoradiography using
intensifying screens, and adduct levels were
calculated from the amount ofradioactivity
on the chromatograms, DNA, and the
specific activity of [y-32P]ATP used for the
labeling (18).
HPLCAnalysis
HPLC separation was carried out according
to Pfau and Phillips (20) and King et al.
(16) with slight modifications. The Varian
Model 5500 (Varian, Walnut Creek, CA)
B
was used for HPLC, and radioactivity was
determined with the flow-through scintilla-
tion counter Model IC/CR Flo-One\p
(Radiomatic Instruments & Chemical Co.,
Inc., Tampa, FL) using 2.5 ml/cell and a
scintillator flow rate of 1.8 ml/min. The
radioactive spots were eluted from TLC
plates by extracting in 400 pl of4 M pyri-
dinium formate, pH 4.0, for 18 hr. The
adduct residues were separated in an Inerstil
ODS-2 column (5 pm particle size, 2.1
mmx 150 mm; GL Sciences Inc.) with a
flow rate of0.45 ml/min. The solvent sys-
tem used 0.3 M NaH2PO4/H3PO4, pH
2.5, and 100% MeOH. HPLC samples
were separated with two gradient systems:
gradient Awas increased with MeOH from
10 to 50% in 0 to 20 min, 50 to 90% in
20 to 40 min, 90 to 70% in 40 to 50 min,
70 to 10% in 50 to 53 min, and to 10% in
70 min; gradient B was increased with
MeOH from 10 to 45% in 0 to 15 min, 45
to 48% in 15 to 60 min, 48 to 90% in 60
to 80 min, 90 to 10% in 80 to 81 min, and
to 10% in 90 min.
C
Figure 1. Autoradiographs of 32P-postlabeled human DNA. CT DNA was modified in vitro with DCM extract, and PAH and nitro-PAH were activated by the S9 mix and
xanthine oxidase. A and B, 1-NP-DNA adducts analyzed by the postlabeling assay enhanced by nuclease P1 and butanol extraction, respectively. C, In vitro-prepared
anti(±)BPDE-DNA adduct standard. Dand E, Diagonal radioactive zone of in vitro-modified CT DNA analyzed on 10x10 cm and 20x20 cm TLC plates, respectively (1-4 are
migrating DNA adducts). F, 32P-postlabeled DNA digest from WBC of an exposed foundryworker(black circle shows the area excised forthe quantitation of adducts; adducts
3 and 4 were not detected). All samples shown in Bthrough Fwere analyzed by the butanol extraction. Autoradiography was carried out at room temperature for 1 min for
Athrough Cand 5 hrfor Dand Eand at-70°Cfor 3 days for F
Environmental Health Perspectives - Vol 104, Supplement 3 * May 1996 688IN VITRO CHARACTERIZATION OF DNAADDUCTS
Results and Discussion
During the 1980s, a series of biomarker
studies was initiated in iron foundry
workers. DNA adducts were analyzed in
white blood cells (WBC) ofthese workers
by Phillips et al. (21) using a 32P-postlabel-
ing assay and by Santella et al. (22) using an
enzyme-linked immunoassay. In this study,
B[a]P levels in the workplace atmosphere
ranged from 7 to 41 ng/m3, which are about
50-fold lower than the B[a]P levels of2 to 3
xg/m3 measured earlier (1979-1980) in the
same foundry (23). The 1990 PAH mea-
surements were determined by personal
monitors worn by the workers; the B[a]P
levels ranged from 2 to 60 ng/m3 (22).
The concentration of B[a]P in the
composited extract offoundry air particles
was 8.2 ng/mg EOM. 1-NP was also quan-
titated in this extract at the concentration
comparable to B[a]P (10.9 ng/mg). Figures
IA and 1B show the autoradiographs from
the 1-NP-DNA standard using both
nuclease P1 and butanol extraction. Figure
IC shows the anti(±)BPDE-DNA adduct
standard analyzed by butanol extraction.
1-NP was only detected by the butanol
extraction-enhanced 32P-postlabeling assay.
The DNA adducts formed from a foundry
sample show a diagonal radioactive zone of
adducts obtained on both lOx 10 and
20 x20 cm TLC from the in vitro with
DCM extract-modified CT DNA using
the butanol extraction-enhanced 32P-post-
labeling assay (Figures 1D, IE). The chro-
matography on the 20x20 cm TLC plates
showed separation more clearly (Figure
lE). Foundry DNA adducts formed by
xanthine oxidase were barely detectable
(data not shown). In the presence of S9
mix, relatively high levels ofseveral DNA
adducts were observed. DNA adducts
detected by the butanol extraction from a
300 - A
foundry worker's WBC DNA showed low
levels of radioactivity, and no DNA
adducts were detected on the area of 1-NP
(Figure IF). However, DNA adducts
migrating close to the origin could corre-
spond to adducts 1 and 2 detected on
10x 10 cm TLC plates from the in vitro
foundry DNA samples (Figure 1D).
Further migrating DNA adducts 3 and 4
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(Figure 1D) were not detected in foundry
workers' WBC DNA.
TLC combined with HPLC was used
in this study to characterize PAH standards
and adducts formed in CT DNA incu-
bated with foundry filter DCM extract.
Anti(±)BPDE- and 1-NP-DNA adducts
were eluting close together when gradient
A was used in HPLC analysis (Figure 2A);
dduct 3 +antil±)BPDE-DNA
0 10 20 30 40 50
Time, min
Figure 2. HPLC analysis of anti(±)BPDE- (dashed line)
and 1-NP-DNA (solid line) adduct standards. A, separa-
tion using gradient A; B, the separation by the modified
gradient B.
Figure 3. HPLC analysis of postlabeled adducts formed in vitro in CT DNA modified with DCM extract and S9 mix
using gradient A. A, C, E, and G show CT DNA adducts obtained on TLC. B, D, F, and Hshow, respectively, the
same adducts spiked with anti(±)BPDE-DNA adduct standard before the HPLC analysis.
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however, the modified gradient B separated
PAH standards distinctly (Figure 2B).
Gradient A, however, was used further in
this study because no 1-NP adducts were
detected on TLC. The anti(±)BPDE-DNA
adduct standard was used as a marker com-
pound in HPLC analysis in characterizing
PAH adducts formed in CT incubated with
DCM extract (Figures 3A-H). Figure 3A,
3C, 3E, and 3G show the HPLC analysis
of four adducts obtained on both 10 x 10
or 20x20 cm TLC plates (Figures 1D, IE).
These in vitro adduct residues were
analyzed first by HPLC; the same four
residues were spiked before the HPLC with
the anti(±)BPDE-DNA adduct standard
(Figures 3B, 3D, 3F, 3H). The main peak
ofadduct 2 is most probably derived from
B[a]P based on co-migration with the
anti(±)BPDE-DNA standard (Figures 3C,
3D). The development ofthe methodology
in analyzing nitro-PAH-DNA adducts in
exposed humans by these two techniques
still needs to be improved; however,
promising results have been reported in
analyzing PAH and nitro-PAH adducts
from in vivo DNA (16,24-26). This study
confirms that the 32P-postlabeling method
combined with HPLC is an applicable
method for the characterization of PAH
adducts in in vitro DNA exposed to com-
plex mixtures ofPAHs. The ultimate objec-
tives ofthese studies are to characterize and
identify specific PAH- and nitro-PAH-
DNA adducts in human cells from exposed
foundryworkers.
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